1
|
Isiiko J, Kiptoo J, Yadesa TM, Mwandah DC, Alinaiswe R, Ngonzi J, Alele PE. Potentially harmful medication use and the associated factors among pregnant women visiting antenatal care clinics in Mbarara Regional Referral Hospital, Southwestern Uganda. J Clin Transl Res 2022; 9:16-25. [PMID: 36687297 PMCID: PMC9844225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 11/26/2022] [Accepted: 11/29/2022] [Indexed: 01/24/2023] Open
Abstract
Background Pregnancy management using medications has been challenging for both healthcare providers and pregnant women, given the fear of teratogenicity effects and the potential for fetal harm. In the developing world, poor health-seeking behavior of patients, delayed initiation of antenatal care (ANC), and low level of educational status of mothers could contribute to the issue of drug safety in pregnancy. Aim The aim of the study was to determine the prevalence and factors associated with potentially harmful medication use in pregnancy. Methods A cross-sectional study was conducted from April 1 to June 6, 2021, including 209 pregnant women on ANC follow-up at a referral hospital in Southwestern Uganda. The simple random sampling technique was employed to select study participants. Interviewer-administered questionnaires were used to collect the history of medication use since conception and then the participant's ANC card was reviewed to determine prescribed drug regimens and their indications. Statistical Package for the Social Sciences version 23.0 was used for analysis. Results Out of the 1,422 medications used by 209 women, 665 (42.2%) were category C, and 182 (11.5%) were category A. A total of 92 (44.0%) pregnant women used at least one potentially harmful medication during the current pregnancy. Having more than average monthly income (adjusted odds ratio [aOR] = 2.32 [1.04, 5.14 at 95% confidence interval (CI)]), having a chronic disease (aOR = 3.24 [1.17, 8.97 at 95% C.I]), using 7 and more medications (aOR = 9.12 [4.11, 20.24 at 95% CI]), and use of herbal medicines (aOR = 4.50 [2.10, 9.87 at 95% CI]) were shown to be risk factors. Conclusion The proportion of pregnant women that used at least one potentially harmful medication is higher than in previous studies. Having comorbidities and taking more medications increase the risk of receiving a potentially harmful medication during pregnancy. Relevance to Patients This study identified the gaps in the use of medicines during pregnancy which will enable the development and implementation of protocols for optimizing prescribing practices in pregnant women by focusing on the safety of the fetus.
Collapse
Affiliation(s)
- John Isiiko
- 1Department of Pharmacy, Mbarara University of Science and Technology, Mbarara, Uganda,2Department of Pharmacy, Uganda Cancer Institute, Mbarara, Uganda,Corresponding author: John Isiiko Department of Pharmacy, Mbarara University of Science and Technology, Mbarara, Uganda/Department of Pharmacy, Uganda Cancer Institute, Mbarara, Uganda. Tel: +256704441100.
| | - Joshua Kiptoo
- 1Department of Pharmacy, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Tadele Mekuriya Yadesa
- 1Department of Pharmacy, Mbarara University of Science and Technology, Mbarara, Uganda,3Department of Pharmacy, Ambo University, Ambo, Ethiopia
| | - Daniel Chans Mwandah
- 4Department of Pharmacology, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Rachel Alinaiswe
- 1Department of Pharmacy, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Joseph Ngonzi
- 5Department of Obstetrics and Gynecology, Mbarara University of Science and Technology, Mbarara, Uganda
| | - Paul E. Alele
- 4Department of Pharmacology, Mbarara University of Science and Technology, Mbarara, Uganda
| |
Collapse
|
2
|
Kiyimba K, Ayikobua ET, Mwandah DC, Obakiro SB. Assessing the protective effect of Crassocephalum vitellinum against Rifampicin- induced hepatotoxicity in Wistar rats. Afr Health Sci 2022; 22:352-360. [PMID: 36032444 PMCID: PMC9382464 DOI: 10.4314/ahs.v22i1.43] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Background: Crassocephalum vitellinum is widely used by traditional medical practitioners and local people in East Africa to manage a large number of ailments including hepatitis 1. However, its hepatoprotective effects had not been evaluated prior to this study. The aim of this study was to assess the effect of an ethanolic leaf extract of Crassocephalum vitellinum against rifampicin-induced liver toxicity in Wistar rats.
Methods: Increasing doses of an ethanolic leaf extract of C. vitellinum were administered to Wistar rats daily for 35 days, together with rifampicin given orally as suspension. After the treatment period, Assessment of hepatoprotective activity was done by analysis of serum levels of biochemical and histopathological effects on the liver.
Results: The results showed that administration of C. vitellinum extract significantly prevented drug- induced increase in serum levels of liver biomarker enzymes and also decreased the hepatocellular necrosis and inflammatory cells infiltration.Conclusion: The plant extract loweres the liver biomarker enzymes (ALT, ALP, AST) and preserves the histomorphology of the hepatocytes which is suggestive that the plant possess hepatoprotective properties.
Keywords: Crassocephalum vitellinum; antitubercular drugs; drug-induced hepatotoxicity; hepatoprotective agents.
Collapse
Affiliation(s)
- Kenedy Kiyimba
- Department of Pharmacology and Therapeutics, Faculty of health sciences, Busitema University
- Department of Pharmacology and Toxicology, School of Pharmacy, Kampala International Univrsity, Western Campus
| | | | - Daniel Chans Mwandah
- Department of Pharmacology and Toxicology, School of Pharmacy, Kampala International Univrsity, Western Campus
| | - Samuel Baker Obakiro
- Department of Pharmacology and Therapeutics, Faculty of health sciences, Busitema University
| |
Collapse
|
3
|
Ayikobua ET, Kasolo J, Kasozi KI, Eze ED, Safiriyu A, Ninsiima HI, Kiyimba K, Namulema J, Jjesero E, Ssempijja F, Semuyaba I, Mwandah DC, Kimanje KR, Kalange M, Okpanachi AO, Nansunga M. Synergistic action of propolis with levodopa in the management of Parkinsonism in Drosophila melanogaster. J Complement Integr Med 2020; 17:jcim-2019-0136. [PMID: 32386191 DOI: 10.1515/jcim-2019-0136] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2019] [Accepted: 10/13/2019] [Indexed: 06/11/2023]
Abstract
Background The Phosphatase and tensin-induced putative kinase 1 (PINK1B9) mutant for Drosophila melanogaster is a key tool that has been used in assessing the pathology of Parkinsonism and its possible remedy. This research was targeted toward determining the effects of ethanolic extract of propolis, with levodopa therapy in the management of Parkinsonism. Method The PINK1B9 flies were divided into groups and fed with the different treatment doses of ethanoic extract of propolis. The treatment groups were subjected to 21 days of administration of propolis and the levodopa at different doses after which percentage climbing index, antioxidant activity and lifespan studies were done. Results Propolis alone improved motor activity, antioxidant and lifespan in Drosophila melanogaster than in PINK1 flies. Propolis in combination with levodopa significantly (P<0.05) improved physiological parameters at higher than lower concentrations in Parkinsonism Drosophila melanogaster demonstrating its importance in managing side effects associated with levodopa. Conclusion Propolis is a novel candidate as an alternative and integrative medicinal option to use in the management of Parkinsonism in both animals and humans at higher concentrations.
Collapse
Affiliation(s)
- Emmanuel Tiyo Ayikobua
- Department of Physiology, School of Health Sciences, Soroti University, 211Soroti, Uganda
- Department of Physiology, Faculty of Health Sciences, Busitema University Mbale Campus, Box 203Mbale, Uganda
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
- Institute of Biomedical Research Laboratory, Kampala International University, Western Campus, Box 71, Bushenyi, Uganda
| | - Josephine Kasolo
- Department of Physiology, Makerere University College of health Science, Box 7072, KampalaUganda
| | - Keneth Iceland Kasozi
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
- Institute of Biomedical Research Laboratory, Kampala International University, Western Campus, Box 71, Bushenyi, Uganda
- Department of Animal Production and Management, Faculty of Agriculture and Animal Sciences, Busitema University Arapai Campus, Box 203Soroti, Uganda
| | - Ejike Daniel Eze
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
| | - Abass Safiriyu
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
- Institute of Biomedical Research Laboratory, Kampala International University, Western Campus, Box 71, Bushenyi, Uganda
| | - Herbert Izo Ninsiima
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
- Department of Physiology, School of Medicine, Kabale University, Box 317Kabale, Uganda
| | - Kennedy Kiyimba
- Department of Pharmacology, Faculty of Pharmacy, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
| | - Jackline Namulema
- Department of Physiology, School of Health Sciences, Uzima University College - CUEA, P.O Box 2502-40100, Kisumu, Kenya
| | - Edward Jjesero
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
- Institute of Biomedical Research Laboratory, Kampala International University, Western Campus, Box 71, Bushenyi, Uganda
| | - Fred Ssempijja
- Department of Anatomy, Faculty of Biomedical Sciences, Kampala International University estern Campus, Box 71, Bushenyi, Uganda
| | - Ibrahim Semuyaba
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
| | - Daniel Chans Mwandah
- Department of Pharmacology, Faculty of Pharmacy, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
| | - Kyobe Ronald Kimanje
- Department of Biochemistry, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
| | - Muhamudu Kalange
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
| | - Alfred Omachonu Okpanachi
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
- Institute of Biomedical Research Laboratory, Kampala International University, Western Campus, Box 71, Bushenyi, Uganda
| | - Miriam Nansunga
- Department of Physiology, Faculty of Biomedical Sciences, Kampala International University Western Campus, Box 71, Bushenyi, Uganda
- Department of Physiology, Faculty of Biomedical Sciences, St. Augustine International University, P.O Box 88, Kampala, Uganda
| |
Collapse
|